These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

792 related articles for article (PubMed ID: 33618961)

  • 1. Successful Perioperative Management of Orthotopic Cardiac Transplantation in a Pediatric Patient With Concurrent Congenital von Willebrand Disease and Acquired von Willebrand Syndrome Using Recombinant von Willebrand Factor.
    Batsuli G; Zimowski KL; Carroll R; White MH; Woods GM; Meeks SL; Sidonio RF
    J Cardiothorac Vasc Anesth; 2022 Mar; 36(3):724-727. PubMed ID: 33618961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired von Willebrand syndrome in congenital heart disease surgery: results from an observational case-series.
    Icheva V; Nowak-Machen M; Budde U; Jaschonek K; Neunhoeffer F; Kumpf M; Hofbeck M; Schlensak C; Wiegand G
    J Thromb Haemost; 2018 Nov; 16(11):2150-2158. PubMed ID: 29908036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel ELISA-based diagnosis of acquired von Willebrand disease with increased VWF proteolysis.
    Rauch A; Caron C; Vincent F; Jeanpierre E; Ternisien C; Boisseau P; Zawadzki C; Fressinaud E; Borel-Derlon A; Hermoire S; Paris C; Lavenu-Bombled C; Veyradier A; Ung A; Vincentelli A; van Belle E; Lenting PJ; Goudemand J; Susen S
    Thromb Haemost; 2016 May; 115(5):950-9. PubMed ID: 26791163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired von Willebrand syndrome--report of 10 cases and review of the literature.
    Nitu-Whalley IC; Lee CA
    Haemophilia; 1999 Sep; 5(5):318-26. PubMed ID: 10583513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization, classification, and treatment of von Willebrand diseases: a critical appraisal of the literature and personal experiences.
    Michiels JJ; Gadisseur A; Budde U; Berneman Z; van der Planken M; Schroyens W; van de Velde A; van Vliet H
    Semin Thromb Hemost; 2005 Nov; 31(5):577-601. PubMed ID: 16276467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal bleeding in von Willebrand patients: special diagnostic and management considerations.
    Ocran E; Chornenki NLJ; Bowman M; Sholzberg M; James P
    Expert Rev Hematol; 2023; 16(8):575-584. PubMed ID: 37278227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Utility of von Willebrand Factor Propeptide in the Differential Diagnosis of von Willebrand Disease and Acquired von Willebrand Syndrome.
    Stufano F; Boscarino M; Bucciarelli P; Baronciani L; Maino A; Cozzi G; Peyvandi F
    Semin Thromb Hemost; 2019 Feb; 45(1):36-42. PubMed ID: 29913537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of inhibitors in acquired von Willebrand syndrome.
    Mohri H; Motomura S; Kanamori H; Matsuzaki M; Watanabe S; Maruta A; Kodama F; Okubo T
    Blood; 1998 May; 91(10):3623-9. PubMed ID: 9572997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired von Willebrand Syndrome: An Under-Recognized Cause of Major Bleeding in the Cardiac Intensive Care Unit.
    Jones MB; Ramakrishnan K; Alfares FA; Endicott KM; Oldenburg G; Berger JT; Shankar V; Nath DS; Diab YA
    World J Pediatr Congenit Heart Surg; 2016 Nov; 7(6):711-716. PubMed ID: 27834763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and therapeutic management in a patient with type 2B-like acquired von Willebrand syndrome.
    Karger R; Weippert-Kretschmer M; Budde U; Kretschmer V
    Blood Coagul Fibrinolysis; 2011 Mar; 22(2):144-7. PubMed ID: 21178586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory Testing for von Willebrand Factor: Factor VIII Binding (for 2N VWD).
    Mohammed S; Favaloro EJ
    Methods Mol Biol; 2017; 1646():461-472. PubMed ID: 28804848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of von Willebrand Disease.
    Curnow J; Pasalic L; Favaloro EJ
    Semin Thromb Hemost; 2016 Mar; 42(2):133-46. PubMed ID: 26838696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and laboratory phenotype variability in type 2M von Willebrand disease.
    Doruelo AL; Haberichter SL; Christopherson PA; Boggio LN; Gupta S; Lentz SR; Shapiro AD; Montgomery RR; Flood VH
    J Thromb Haemost; 2017 Aug; 15(8):1559-1566. PubMed ID: 28544236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory diagnosis and molecular classification of von Willebrand disease.
    Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
    Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and treatment of acquired von Willebrand syndrome.
    Tiede A
    Thromb Res; 2012 Dec; 130 Suppl 2():S2-6. PubMed ID: 23439003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
    Michiels JJ; van Vliet HH; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van der Velden A; Budde U
    Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classification and characterization of hereditary types 2A, 2B, 2C, 2D, 2E, 2M, 2N, and 2U (unclassifiable) von Willebrand disease.
    Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
    Clin Appl Thromb Hemost; 2006 Oct; 12(4):397-420. PubMed ID: 17000885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How we diagnose 2M von Willebrand disease (VWD): Use of a strategic algorithmic approach to distinguish 2M VWD from other VWD types.
    Favaloro EJ; Mohammed S; Vong R; Oliver S; Brennan Y; Favaloro JW; Curnow J
    Haemophilia; 2021 Jan; 27(1):137-148. PubMed ID: 33215808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory Diagnosis of von Willebrand Disease (VWD): Geographical Perspectives.
    Favaloro EJ; Pasalic L
    Semin Thromb Hemost; 2022 Sep; 48(6):750-766. PubMed ID: 36055264
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 40.